Chen et al. [32] discovered that the TGF-βR1 rs334348 polymorphism may modulate the progression of oral cancer by regulating the expression of TGF-βR1 and diminishing its ability to phosphorylate Smad-2 and Smad-3. This evidence concerns the gene SMAD2 and lip and oral cavity carcinoma.